{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:50:12Z","timestamp":1792788612567,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"European Union's Seventh Framework Programme","doi-asserted-by":"publisher","award":["601783"],"award-info":[{"award-number":["601783"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BELLEROPHON project"},{"name":"Oxford Biomedical Research Centre","id":[{"id":"https:\/\/ror.org\/00k27zs44","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009033","name":"NHS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.vaccine.2018.11.036","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T00:21:39Z","timestamp":1543364499000},"page":"502-509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease"],"prefix":"10.1016","volume":"37","author":[{"given":"Elizaveta","family":"Elshina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Flaxman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline M.","family":"van Diemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Milicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine S.","family":"Rollier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9155-6228","authenticated-orcid":false,"given":"David H.","family":"Wyllie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.11.036_b0005","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lowy","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.11.036_b0010","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3389\/fmicb.2016.00449","article-title":"Fecal carriage of Staphylococcus aureus in the hospital and community setting: a systematic review","volume":"7","author":"Claassen-Weitz","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2018.11.036_b0015","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1212788","article-title":"Management of skin abscesses in the era of methicillin-resistant Staphylococcus aureus","volume":"370","author":"Singer","year":"2014","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2018.11.036_b0020","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0924-8579(10)70003-0","article-title":"The continuing crisis in antibiotic resistance","volume":"36","author":"French","year":"2010","journal-title":"Int J Antimicrob Agent"},{"key":"10.1016\/j.vaccine.2018.11.036_b0025","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/jama.2013.3010","article-title":"Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial","volume":"309","author":"Fowler","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2018.11.036_b0030","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa011297","article-title":"Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis","volume":"346","author":"Shinefield","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.11.036_b0035","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1128\/CDLI.8.6.1271-1276.2001","article-title":"Analogs of Eap protein are conserved and prevalent in clinical Staphylococcus aureus isolates","volume":"8","author":"Hussain","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2018.11.036_b0040","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1038\/ncomms4956","article-title":"Mobile elements drive recombination hotspots in the core genome of Staphylococcus aureus","volume":"5","author":"Everitt","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2018.11.036_b0045","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jinf.2013.12.013","article-title":"Dynamics of acquisition and loss of carriage of Staphylococcus aureus strains in the community: the effect of clonal complex","volume":"68","author":"Miller","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2018.11.036_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens5010032","article-title":"Evasion of neutrophil killing by Staphylococcus aureus","volume":"5","author":"McGuinness","year":"2016","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2018.11.036_b0055","doi-asserted-by":"crossref","first-page":"E3101","DOI":"10.1073\/pnas.1520255113","article-title":"Natural mutations in a Staphylococcus aureus virulence regulator attenuate cytotoxicity but permit bacteremia and abscess formation","volume":"113","author":"Das","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2018.11.036_b0060","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrmicro3521","article-title":"Staphylococcal manipulation of host immune responses","volume":"13","author":"Thammavongsa","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2018.11.036_b0065","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1128\/IAI.00230-12","article-title":"Protein A-specific monoclonal antibodies and prevention of Staphylococcus aureus disease in mice","volume":"80","author":"Kim","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.11.036_b0070","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.vaccine.2013.11.054","article-title":"A monoclonal antibody that recognizes the E domain of staphylococcal protein A","volume":"32","author":"Kim","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.036_b0075","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02369-14","article-title":"Protein A suppresses immune responses during Staphylococcus aureus bloodstream infection in guinea pigs","volume":"6","author":"Kim","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2018.11.036_b0080","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.vaccine.2014.11.051","article-title":"Protein A-neutralizing monoclonal antibody protects neonatal mice against Staphylococcus aureus","volume":"33","author":"Thammavongsa","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.036_b0085","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00735-17","article-title":"Staphylococcal protein A contributes to persistent colonization of mice with Staphylococcus aureus","author":"Sun","year":"2018","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2018.11.036_b0090","doi-asserted-by":"crossref","first-page":"13187","DOI":"10.1073\/pnas.1407616111","article-title":"Staphylococcus aureus secretes a unique class of neutrophil serine protease inhibitors","volume":"111","author":"Stapels","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2018.11.036_b0095","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/pro.3342","article-title":"Evidence for multiple modes of neutrophil serine protease recognition by the EAP family of Staphylococcal innate immune evasion proteins","volume":"27","author":"Stapels","year":"2018","journal-title":"Protein Sci"},{"key":"10.1016\/j.vaccine.2018.11.036_b0100","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/cmi.12528","article-title":"Staphylococcus aureus protects its immune-evasion proteins against degradation by neutrophil serine proteases","volume":"18","author":"Stapels","year":"2016","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2018.11.036_b0105","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1110\/ps.073170807","article-title":"The Staphylococcus aureus extracellular adherence protein (Eap) adopts an elongated but structured conformation in solution","volume":"16","author":"Hammel","year":"2007","journal-title":"Protein Sci"},{"key":"10.1016\/j.vaccine.2018.11.036_b0110","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1128\/JB.181.9.2840-2845.1999","article-title":"Adherence of Staphylococcus aureus is enhanced by an endogenous secreted protein with broad binding activity","volume":"181","author":"Palma","year":"1999","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2018.11.036_b0115","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1128\/JB.183.13.3999-4003.2001","article-title":"Rebinding of extracellular adherence protein Eap to Staphylococcus aureus can occur through a surface-bound neutral phosphatase","volume":"183","author":"Flock","year":"2001","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2018.11.036_b0120","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1096\/fj.09-135467","article-title":"Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues","volume":"23","author":"Cheng","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.vaccine.2018.11.036_b0125","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1128\/IAI.00480-08","article-title":"More than one tandem repeat domain of the extracellular adherence protein of Staphylococcus aureus is required for aggregation, adherence, and host cell invasion but not for leukocyte activation","volume":"76","author":"Hussain","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.11.036_b0130","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.matbio.2006.01.005","article-title":"The anchorless adhesin Eap (extracellular adherence protein) from Staphylococcus aureus selectively recognizes extracellular matrix aggregates but binds promiscuously to monomeric matrix macromolecules","volume":"25","author":"Hansen","year":"2006","journal-title":"Matrix Biol"},{"key":"10.1016\/j.vaccine.2018.11.036_b0135","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nm728","article-title":"Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes","volume":"8","author":"Chavakis","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2018.11.036_b0140","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.4049\/jimmunol.1401600","article-title":"The extracellular adherence protein from Staphylococcus aureus inhibits the classical and lectin pathways of complement by blocking formation of the C3 proconvertase","volume":"193","author":"Woehl","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.11.036_b0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.coi.2016.05.014","article-title":"Viral vectors as vaccine platforms: from immunogenicity to impact","volume":"41","author":"Ewer","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2018.11.036_b0150","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/IAI.01187-13","article-title":"Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites","volume":"82","author":"Bauza","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.11.036_b0155","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1038\/ncomms3836","article-title":"Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation","volume":"4","author":"Ewer","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2018.11.036_b0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1128\/IAI.00740-09","article-title":"Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses","volume":"78","author":"Reyes-Sandoval","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.11.036_b0165","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.4049\/jimmunol.1100302","article-title":"CD8+ T effector memory cells protect against liver-stage malaria","volume":"187","author":"Reyes-Sandoval","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.11.036_b0170","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00217-18","article-title":"Two vaccines for Staphylococcus aureus induce a B-cell-mediated immune response","volume":"3","author":"Dupont","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.vaccine.2018.11.036_b0175","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1128\/IAI.00084-13","article-title":"Clearance of Staphylococcus aureus nasal carriage is T cell dependent and mediated through interleukin-17A expression and neutrophil influx","volume":"81","author":"Archer","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.11.036_b0180","doi-asserted-by":"crossref","first-page":"12415","DOI":"10.1038\/s41598-017-12576-0","article-title":"Development of persistent gastrointestinal S. aureus carriage in mice","volume":"7","author":"Flaxman","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2018.11.036_b0185","doi-asserted-by":"crossref","first-page":"e33555","DOI":"10.1371\/journal.pone.0033555","article-title":"Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates","volume":"7","author":"Spencer","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.11.036_b0190","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nm.1850","article-title":"Effective induction of high-titer antibodies by viral vector vaccines","volume":"14","author":"Draper","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2018.11.036_b0195","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0264-410X(01)00450-9","article-title":"Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes","volume":"20","author":"Gilbert","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.036_b0200","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/2049-632X.12042","article-title":"Irradiated wild-type and Spa mutant Staphylococcus aureus induce anti-S. aureus immune responses in mice which do not protect against subsequent intravenous challenge","volume":"68","author":"van Diemen","year":"2013","journal-title":"Pathog Dis"},{"key":"10.1016\/j.vaccine.2018.11.036_b0205","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nmeth.1455","article-title":"Coding of facial expressions of pain in the laboratory mouse","volume":"7","author":"Langford","year":"2010","journal-title":"Nat Meth"},{"key":"10.1016\/j.vaccine.2018.11.036_b0210","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1128\/IAI.59.8.2615-2623.1991","article-title":"Experimental Staphylococcus aureus arthritis in mice","volume":"59","author":"Bremell","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.11.036_b0215","unstructured":"E.R. Allen, et al. MRI based quantification of abscesses following experimental S. aureus intravenous challenge: application to vaccine evaluation."},{"key":"10.1016\/j.vaccine.2018.11.036_b0220","doi-asserted-by":"crossref","first-page":"e0154705","DOI":"10.1371\/journal.pone.0154705","article-title":"MRI based localisation and quantification of abscesses following experimental S. aureus intravenous challenge: application to vaccine evaluation","volume":"11","author":"Allen","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.11.036_b0225","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1472-6750-5-22","article-title":"A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins","volume":"5","author":"Burbelo","year":"2005","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.vaccine.2018.11.036_b0230","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/SLA.0000000000001060","article-title":"Long-term mortality after rapid screening and decolonization of staphylococcus aureus carriers: observational follow-up study of a randomized placebo-controlled trial","volume":"263","author":"Bode","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.vaccine.2018.11.036_b0235","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fcimb.2017.00152","article-title":"Laboratory mice are frequently colonized with Staphylococcus aureus and mount a systemic immune response-note of caution for in vivo infection experiments","volume":"7","author":"Schulz","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2018.11.036_b0240","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1073\/pnas.1424924112","article-title":"Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus","volume":"112","author":"Bagnoli","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2018.11.036_b0245","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.vaccine.2016.02.034","article-title":"Population variation in anti-S. aureus IgG isotypes influences surface protein A mediated immune subversion","volume":"34","author":"Whitehouse","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.036_b0250","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10096-008-0602-7","article-title":"Intestinal carriage of Staphylococcus aureus: how does its frequency compare with that of nasal carriage and what is its clinical impact?","volume":"28","author":"Acton","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.036_b0255","doi-asserted-by":"crossref","first-page":"e00079","DOI":"10.1128\/mBio.00079-16","article-title":"Hidden Staphylococcus aureus carriage: overrated or underappreciated?","volume":"7","author":"van Belkum","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2018.11.036_b0260","doi-asserted-by":"crossref","first-page":"e02039","DOI":"10.1128\/mBio.02039-15","article-title":"The stealthy superbug: the role of asymptomatic enteric carriage in maintaining a long-term hospital outbreak of ST228 methicillin-resistant Staphylococcus aureus","volume":"7","author":"Senn","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2018.11.036_b0265","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1207290","article-title":"Targeted versus universal decolonization to prevent ICU infection","volume":"368","author":"Huang","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.11.036_b0270","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa0808939","article-title":"Preventing surgical-site infections in nasal carriers of Staphylococcus aureus","volume":"362","author":"Bode","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.11.036_b0275","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1086\/678606","article-title":"A randomized, controlled trial of chlorhexidine-soaked cloths to reduce methicillin-resistant and methicillin-susceptible Staphylococcus aureus carriage prevalence in an urban jail","volume":"35","author":"David","year":"2014","journal-title":"Inf Cont Hosp Epidemiol"},{"key":"10.1016\/j.vaccine.2018.11.036_b0280","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1473-3099(13)70295-0","article-title":"Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial","volume":"14","author":"Derde","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.036_b0285","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1086\/666631","article-title":"Chlorhexidine gluconate reduces transmission of methicillin-resistant Staphylococcus aureus USA300 among marine recruits","volume":"33","author":"Whitman","year":"2012","journal-title":"Inf Cont Hosp Epidemiol"},{"key":"10.1016\/j.vaccine.2018.11.036_b0290","doi-asserted-by":"crossref","first-page":"aaf4822","DOI":"10.1126\/science.aaf4822","article-title":"IgA production requires B cell interaction with subepithelial dendritic cells in Peyer\u2019s patches","volume":"352","author":"Reboldi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.11.036_b0295","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1002\/eji.201040440","article-title":"Robust genital gag-specific CD8+ T-cell responses in mice upon intramuscular immunization with simian adenoviral vectors expressing HIV-1-gag","volume":"40","author":"Haut","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2018.11.036_b0300","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.vaccine.2006.11.044","article-title":"Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut","volume":"25","author":"Lin","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.036_b0305","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/blood-2007-02-062117","article-title":"Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines","volume":"110","author":"Tatsis","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2018.11.036_b0310","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1099\/vir.0.83018-0","article-title":"Virus distribution of the attenuated MVA and NYVAC poxvirus strains in mice","volume":"88","author":"Gomez","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.11.036_b0315","series-title":"Staphylococcus aureus Current Topics in Microbiology and Immunology","doi-asserted-by":"crossref","DOI":"10.1007\/82_2016_54","article-title":"Vaccines for Staphylococcus aureus and Target Populations","author":"Pozzi","year":"2016"},{"key":"10.1016\/j.vaccine.2018.11.036_b0320","doi-asserted-by":"crossref","first-page":"e1002454","DOI":"10.1371\/journal.pcbi.1002454","article-title":"Quantifying type-specific reproduction numbers for nosocomial pathogens: evidence for heightened transmission of an Asian sequence type 239 MRSA clone","volume":"8","author":"Cooper","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.vaccine.2018.11.036_b0325","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1093\/jac\/dkv169","article-title":"Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA","volume":"70","author":"Poovelikunnel","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2018.11.036_b0330","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02000-17","article-title":"Topical antibiotic use coselects for the carriage of mobile genetic elements conferring resistance to unrelated antimicrobials in Staphylococcus aureus","volume":"62","author":"Carter","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T20:28:17Z","timestamp":1662496097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18315597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0264410X18315597"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}